Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS: ELTP · Delayed Price · USD
0.133
+0.003 (2.32%)
Apr 26, 2024, 3:59 PM EDT - Market closed
Elite Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Year | Current | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 135 | 29 | 35 | 57 | 58 | 81 | 80 | 126 | 209 | 148 | 189 | Upgrade
|
| Market Cap Growth | - | -16.84% | -37.57% | -2.89% | -28.44% | 2.27% | -36.72% | -39.78% | 41.34% | -21.61% | 671.64% | Upgrade
|
| Enterprise Value | 137 | 25 | 30 | 56 | 61 | 83 | 76 | 118 | 201 | 143 | 186 | Upgrade
|
| PE Ratio | 8.72 | 0.01 | 3.97 | 11.12 | -26.01 | -8.77 | -21.67 | 33.01 | -305.87 | 5.11 | -1.95 | Upgrade
|
| PS Ratio | 2.85 | 0.00 | 1.09 | 2.23 | 3.24 | 10.76 | 10.67 | 13.05 | 16.72 | 29.47 | 40.98 | Upgrade
|
| PB Ratio | 2.91 | 1.01 | 1.40 | 3.50 | 5.47 | 7.14 | 4.31 | 4.90 | 18.71 | -4.26 | -2.32 | Upgrade
|
| P/FCF Ratio | -42.69 | -12.25 | 5.88 | 19.76 | -31.86 | -11.95 | -15.66 | -14.00 | -44.31 | -8.64 | -39.47 | Upgrade
|
| P/OCF Ratio | -59.55 | 8.80 | 5.43 | 17.72 | -32.48 | -11.99 | -16.55 | -15.96 | -75.54 | -9.79 | -44.71 | Upgrade
|
| EV/Sales Ratio | 2.89 | 0.00 | 0.92 | 2.20 | 3.40 | 10.98 | 10.24 | 12.23 | 16.09 | 28.61 | 40.34 | Upgrade
|
| EV/EBITDA Ratio | 16.40 | 0.01 | 4.54 | 15.36 | -80.17 | -10.55 | -9.51 | -17.78 | -784.31 | -9.03 | -38.97 | Upgrade
|
| EV/EBIT Ratio | 19.61 | 0.01 | 5.83 | 26.49 | -26.90 | -9.10 | -8.46 | -16.05 | -217.87 | -8.71 | -35.58 | Upgrade
|
| EV/FCF Ratio | -43.31 | -10.60 | 4.92 | 19.47 | -33.44 | -12.20 | -15.03 | -13.11 | -42.65 | -8.39 | -38.86 | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.13 | 0.11 | 0.15 | 0.38 | 0.35 | 0.22 | 0.10 | 0.33 | -0.09 | -0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.94 | 0.00 | 0.43 | 0.66 | -5.28 | -0.51 | -0.50 | -0.40 | -14.23 | -0.20 | -0.84 | Upgrade
|
| Debt / FCF Ratio | -2.37 | -1.62 | 0.46 | 0.83 | -2.20 | -0.58 | -0.78 | -0.29 | -0.77 | -0.18 | -0.84 | Upgrade
|
| Quick Ratio | 1.14 | 1.39 | 1.73 | 1.15 | 0.61 | 0.52 | 1.54 | 3.45 | 2.80 | 1.76 | 1.25 | Upgrade
|
| Current Ratio | 1.94 | 2.75 | 2.82 | 2.10 | 1.19 | 1.28 | 2.68 | 5.50 | 3.59 | 2.43 | 1.61 | Upgrade
|
| Asset Turnover | 0.81 | 835.17 | 0.92 | 0.97 | 0.72 | 0.31 | 0.24 | 0.28 | 0.39 | 0.19 | 0.19 | Upgrade
|
| Interest Coverage | 29.04 | -1.82 | 26.44 | 8.11 | -6.42 | -24.81 | -26.98 | -30.88 | -29.63 | -57.47 | -5.87 | Upgrade
|
| Return on Equity (ROE) | 33.51% | 15227.43% | 35.28% | 31.50% | -21.02% | -81.43% | -19.88% | 14.85% | -6.12% | -83.30% | 118.94% | Upgrade
|
| Return on Assets (ROA) | 20.82% | 10783.21% | 25.32% | 19.43% | -8.98% | -38.03% | -11.89% | 11.11% | -2.14% | 111.61% | -397.14% | Upgrade
|
| Return on Capital (ROIC) | 12.29% | 6821.05% | 23.09% | 13.94% | -15.56% | -59.56% | -40.30% | -47.76% | -56.15% | 52.23% | 6.85% | Upgrade
|
| Earnings Yield | 11.53% | 15012.72% | 25.19% | 8.99% | -3.85% | -11.40% | -4.61% | 3.03% | -0.33% | 19.57% | -51.22% | Upgrade
|
| FCF Yield | -2.47% | -8.16% | 17.01% | 5.06% | -3.14% | -8.37% | -6.39% | -7.15% | -2.26% | -11.57% | -2.53% | Upgrade
|
| Buyback Yield / Dilution | -1.04% | -0.23% | -7.17% | -13.30% | -1.96% | -2.27% | 5.49% | -25.32% | 11.04% | -63.62% | 12.12% | Upgrade
|
| Total Shareholder Return | -1.04% | -0.23% | -7.17% | -13.30% | -1.96% | -2.27% | 5.49% | -25.32% | 11.04% | -63.62% | 12.12% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.